Consequently, future research should prioritize the development and utilization of VCR-resistant ALL cell lines to further investigate the role of PTPN21 in drug resistance and assess its potential as a therapeutic target. The gene discussed is PTPN21; the disease is acute lymphoblastic leukemia.